2-amino-5-phosphonomethyl(1,1'-biphenyl)-3-propanoic acid has been researched along with levodopa in 1 studies
| Studies (2-amino-5-phosphonomethyl(1,1'-biphenyl)-3-propanoic acid) | Trials (2-amino-5-phosphonomethyl(1,1'-biphenyl)-3-propanoic acid) | Recent Studies (post-2010) (2-amino-5-phosphonomethyl(1,1'-biphenyl)-3-propanoic acid) | Studies (levodopa) | Trials (levodopa) | Recent Studies (post-2010) (levodopa) |
|---|---|---|---|---|---|
| 9 | 0 | 0 | 17,774 | 1,900 | 4,946 |
| Protein | Taxonomy | 2-amino-5-phosphonomethyl(1,1'-biphenyl)-3-propanoic acid (IC50) | levodopa (IC50) |
|---|---|---|---|
| integrase, partial | Human immunodeficiency virus 1 | 0.5939 | |
| lens epithelium-derived growth factor p75 | Homo sapiens (human) | 0.5939 | |
| Epidermal growth factor receptor | Homo sapiens (human) | 2.88 | |
| Tyrosine-protein kinase Lck | Homo sapiens (human) | 3.729 | |
| Tyrosine-protein kinase Fyn | Homo sapiens (human) | 2.146 | |
| Polyunsaturated fatty acid lipoxygenase ALOX15 | Oryctolagus cuniculus (rabbit) | 2.258 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Campbell, E; Fricker, G; Jenner, P; Lemaire, M; McAllister, KH; Müller, W; Neijt, HC; Park, CK; Perkins, M; Rudin, M; Sauter, A; Smith, L; Urwyler, S; Wiederhold, KH | 1 |
1 other study(ies) available for 2-amino-5-phosphonomethyl(1,1'-biphenyl)-3-propanoic acid and levodopa
| Article | Year |
|---|---|
Biphenyl-derivatives of 2-amino-7-phosphono-heptanoic acid, a novel class of potent competitive N-methyl-D-aspartate receptor antagonists--II. Pharmacological characterization in vivo.
Topics: Amino Acids; Animals; Biphenyl Compounds; Brain; Excitatory Amino Acid Antagonists; Levodopa; Male; Mice; Propionates; Rats; Rats, Inbred F344; Rats, Sprague-Dawley; Rats, Wistar; Receptors, N-Methyl-D-Aspartate | 1996 |